Clinical Trial Update: W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1, single-center, evaluator-blinded, randomized, placebo-controlled trial evaluating the phototoxic potential of a topical clindamycin 1% and tretinoin 0.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• CT Gel

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED